Lincoln Tracy

Melbourne

Sports Journalist with a PhD in Psychology I use my background in academia to tell data-driven sports stories @Monash_SPHPM @Medicalrepublic Opinions are own

Featured in: Favicon

medicalrepublic.com.au Favicon

oncologyrepublic.com.au Favicon

dermatologyrepublic.com.au Favicon

substack.com Favicon

theroar.com.au Favicon

healthservicesdaily.com.au

Articles

New consensus for JAKi use in AD

1 week ago | dermatologyrepublic.com.au | Lincoln Tracy

group of experts from Australia and New Zealand has published over 100 clinical practice statements regarding the use of JAK inhibitors in atopic dermatitis. Unsure about how to best use JAK inhibitors in atopic dermatitis? The Australasian Medical Dermatology Group has a wealth of helpful suggestions. JAK inhibitors have been shown to be safe and effective for the treatment of atopic dermatitis, but there is little practical advice regarding their use.
Advice for JAKi treatment in atopic dermatitis

2 weeks ago | medicalrepublic.com.au | Lincoln Tracy

A group of experts from Australia and New Zealand published over 100 clinical practice statements to help demystify the drugs and improve management. Unsure about how to best use JAK inhibitors in atopic dermatitis? The Australasian Medical Dermatology Group has a wealth of helpful suggestions. JAK inhibitors have been shown to be safe and effective for the treatment of atopic dermatitis, but there is little practical advice regarding their use.
Statins linked to improved survival in leukaemia

2 weeks ago | oncologyrepublic.com.au | Lincoln Tracy

The study, believed to be the first of its kind, suggests the statins do not interfere with the effects of frontline therapies. Statins improved overall, progression-free and cancer-specific survival in a cohort of leukaemia patients. The development of BTK-targeted therapies such as ibrutinib has been a boon for the management of chronic lymphocytic leukaemia and small lymphocytic leukaemia.
Positive results for ctDNA-guided approach to chemo

2 weeks ago | oncologyrepublic.com.au | Lincoln Tracy

Using the ‘very promising technology’ to guide treatment decision-making led to similar recurrence-free survival compared to standard practice. Long-term survival data in early colon cancer patients suggests ctDNA guided chemotherapy use is noninferior to management based on conventional clinicopathological criteria in certain subsets.
ICI use predicted to increase despite adverse events: study

2 weeks ago | oncologyrepublic.com.au | Lincoln Tracy

Dutch researchers have explored the frequency and outcomes of ICI-associated immune-related adverse events in people with cancer. Immune-related adverse events leading to ICU admissions in cancer patients appears to be a price worth paying, according to new research. Immune checkpoint inhibitors have revolutionised the treatment of cancer.
Foam treatment reduces scalp and body psoriasis

2 weeks ago | puffnstuff.com.au | Lincoln Tracy

New research findings present a potential alternative to using creams or ointments on the scalp. Roflumilast foam was successful in reducing psoriasis and itch after eight weeks in a cohort of plaque psoriasis patients. Treating scalp psoriasis is challenging, with the associated pruritus having a significant impact on quality of life and the patient’s hair impacting the effectiveness and application of topical creams and ointments.
Targeted lung cancer therapy added to PBS

2 weeks ago | puffnstuff.com.au | Lincoln Tracy

Amivantamab was made available through the Pharmaceutical Benefits Scheme on 1 May. Login Join Now This content is for members only.
Growing concerns over semaglutide, tirzepatide eye stroke link

2 weeks ago | medicalrepublic.com.au | Lincoln Tracy

TGA complaints add to research suggesting the GLP-1 receptor agonists may be associated with ophthalmic complications. Login Join Now This content is for members only.
Foam treatment reduces scalp and body psoriasis

3 weeks ago | medicalrepublic.com.au | Lincoln Tracy

New research findings present a potential alternative to using creams or ointments on the scalp. Roflumilast foam was successful in reducing psoriasis and itch after eight weeks in a cohort of plaque psoriasis patients. Treating scalp psoriasis is challenging, with the associated pruritus having a significant impact on quality of life and the patient’s hair impacting the effectiveness and application of topical creams and ointments.
Oral JAKi improves phototherapy-induced repigmentation in vitiligo

3 weeks ago | dermatologyrepublic.com.au | Lincoln Tracy

Adding ritlecitib into the cornerstone of vitiligo treatment is an important step forward, according to one expert. Combining an oral JAK inhibitor with ultraviolet phototherapy resulted in an improved therapeutic response in vitiligo, new research has found. Narrow-band ultraviolet B phototherapy and topical JAK inhibitors are commonly used treatments for vitiligo but have poor efficacy and are associated with multiple adverse effects.